Standard Biotools (LAB) Non-Current Deferred Tax Liability (2014 - 2026)

Standard Biotools (LAB) has 13 years of Non-Current Deferred Tax Liability data on file, last reported at $823000.0 in Q1 2026.

• Quarterly Non-Current Deferred Tax Liability fell 20.17% year-over-year to $823000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $823000.0 (down 20.17% YoY) and the FY2025 annual result came in at $810000.0, down 94.43% from the prior year.
• Non-Current Deferred Tax Liability improved to $823000.0 in Q1 2026 per LAB's latest filing, from $810000.0 in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $14.5 million in Q4 2024 and bottomed at $620000.0 in Q3 2022.
• The 5-year median for Non-Current Deferred Tax Liability is $1.0 million (2025), against an average of $1.9 million.
• The widest annual swing landed in 2024, when Non-Current Deferred Tax Liability jumped 1629.01%; it then tumbled 94.43% in 2025.
• Tracing LAB's Non-Current Deferred Tax Liability over 5 years: stood at $1.1 million in 2022, then retreated by 20.28% to $841000.0 in 2023, then jumped by 1629.01% to $14.5 million in 2024, then plunged by 94.43% to $810000.0 in 2025, then gained by 1.6% to $823000.0 in 2026.
• Per Business Quant, the three latest LAB Non-Current Deferred Tax Liability figures stand at $823000.0 (Q1 2026), $810000.0 (Q4 2025), and $1.1 million (Q3 2025).

Peer Comparison